Bristol-Myers Squibb Co. v. AstraZeneca Pharmaceuticals LP
1:17-cv-01028
Overview
Parties
Defendant
AstraZeneca Pharmaceuticals, LP NPE (Individual / Inventor)
Represented By
13 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
AstraZeneca UK Ltd. Operating Company
Represented By
5 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Tasuku Honjo NPE (Individual / Inventor)
Represented By
9 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Akin Gump Strauss Hauer & Feld LLP
1735 Market Street, Ste 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Bristol-Myers Squibb Co. Operating Company
Represented By
13 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Akin Gump Strauss Hauer & Feld LLP
1735 Market Street, Ste 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Counter Defendant
Ono Pharmaceutical Co., Ltd. Operating Company
Represented By
9 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Akin Gump Strauss Hauer & Feld LLP
1735 Market Street, Ste 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
E. R. Squibb & Sons L.L.C. Operating Company
Represented By
9 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Akin Gump Strauss Hauer & Feld LLP
1735 Market Street, Ste 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 9,402,899 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,073,994 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,067,999 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,393,301 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,439,962 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017005106 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2020006284 | US Continuation / Sibling | View Official Patent → |
| 🇯🇵 Japan | JP 2002194491 | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 2003029846 | Japan Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2004004771 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 7,595,048 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,168,179 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,728,474 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9402899
Immunopotentiative composition
|
Filed: 2014-04-04
Issued: 2016-08-02
|
Expired (Term Ended)
Expires: 2024-02-05
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
28
Dispositive
0
Granted
1
Denied
0
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings